Literature DB >> 24206455

microRNAs in cancer cell response to ionizing radiation.

Jennifer R Czochor1, Peter M Glazer.   

Abstract

SIGNIFICANCE: microRNAs (miRNA) have been characterized as master regulators of the genome. As such, miRNAs are responsible for regulating almost every cellular pathway, including the DNA damage response (DDR) after ionizing radiation (IR). IR is a therapeutic tool that is used for the treatment of several types of cancer, yet the mechanism behind radiation response is not fully understood. RECENT ADVANCES: It has been demonstrated that IR can alter miRNA expression profiles, varying greatly from one cell type to the next. It is possible that this variation contributes to the range of tumor cell responsiveness that is observed after radiotherapy, especially considering the extensive role for miRNAs in regulating the DDR. In addition, individual miRNAs or miRNA families have been shown to play a multifaceted role in the DDR, regulating multiple members in a single pathway. CRITICAL ISSUES: In this review, we will discuss the effects of radiation on miRNA expression as well as explore the function of miRNAs in regulating the cellular response to radiation-induced damage. We will discuss the importance of miRNA regulation at each stage of the DDR, including signal transduction, DNA damage sensing, cell cycle checkpoint activation, DNA double-strand break repair, and apoptosis. We will focus on emphasizing the importance of a single miRNA targeting several mediators within a pathway. FUTURE DIRECTIONS: miRNAs will continue to emerge as critical regulators of the DDR. Understanding the role of miRNAs in the response to IR will provide insights for improving the current standard therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24206455      PMCID: PMC4066235          DOI: 10.1089/ars.2013.5718

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  173 in total

1.  MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway.

Authors:  Chunzhi Zhang; Chunsheng Kang; Ping Wang; Yongzhen Cao; Zhonghong Lv; Shizhu Yu; Guangxiu Wang; Anling Zhang; Zhifan Jia; Lei Han; Chunying Yang; Hiromichi Ishiyama; Bin S Teh; Bo Xu; Peiyu Pu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-01       Impact factor: 7.038

2.  Micro RNA responses to chronic or acute exposures to low dose ionizing radiation.

Authors:  M Ahmad Chaudhry; Romaica A Omaruddin; Bridget Kreger; Sonia M de Toledo; Edouard I Azzam
Journal:  Mol Biol Rep       Date:  2012-02-25       Impact factor: 2.316

3.  Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.

Authors:  Keitaro Yamane; Masatoshi Jinnin; Tomomi Etoh; Yuki Kobayashi; Naoki Shimozono; Satoshi Fukushima; Shinichi Masuguchi; Keishi Maruo; Yuji Inoue; Tsuyoshi Ishihara; Jun Aoi; Yuichi Oike; Hironobu Ihn
Journal:  J Mol Med (Berl)       Date:  2012-07-25       Impact factor: 4.599

4.  Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.

Authors:  Jeong-Eun Kwon; Bu-Yeon Kim; Seo-Young Kwak; In-Hwa Bae; Young-Hoon Han
Journal:  Apoptosis       Date:  2013-07       Impact factor: 4.677

5.  MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia.

Authors:  Marek Mraz; Dasa Dolezalova; Karla Plevova; Katerina Stano Kozubik; Veronika Mayerova; Katerina Cerna; Katerina Musilova; Boris Tichy; Sarka Pavlova; Marek Borsky; Jan Verner; Michael Doubek; Yvona Brychtova; Martin Trbusek; Ales Hampl; Jiri Mayer; Sarka Pospisilova
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

6.  MicroRNA-182-5p targets a network of genes involved in DNA repair.

Authors:  Keerthana Krishnan; Anita L Steptoe; Hilary C Martin; Shivangi Wani; Katia Nones; Nic Waddell; Mythily Mariasegaram; Peter T Simpson; Sunil R Lakhani; Brian Gabrielli; Alexander Vlassov; Nicole Cloonan; Sean M Grimmond
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

Review 7.  Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.

Authors:  Benjamin H Lok; Simon N Powell
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

8.  miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.

Authors:  Lin Xia; Dexin Zhang; Rui Du; Yanglin Pan; Lina Zhao; Shiren Sun; Liu Hong; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

9.  Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family.

Authors:  Lynn M Pouliot; Yu-Chi Chen; Jennifer Bai; Rajarshi Guha; Scott E Martin; Michael M Gottesman; Matthew D Hall
Journal:  Cancer Res       Date:  2012-08-31       Impact factor: 12.701

10.  miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.

Authors:  Libing Song; Chuyong Lin; Zhiqiang Wu; Hui Gong; Yong Zeng; Jueheng Wu; Mengfeng Li; Jun Li
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

View more
  39 in total

Review 1.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

2.  IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy.

Authors:  X Fang; J-H Jeong; X Long; S-J Park; D Wang; M Shuai; R Wei; C Li; S Li; S Zhang; M B Duran; K-W Lo; S W Tsao; R Glaser; Z Luo; X Feng; Y Tian; J-L Luo
Journal:  Cell Death Differ       Date:  2016-04-08       Impact factor: 15.828

3.  miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.

Authors:  Jinpeng He; Xiu Feng; Junrui Hua; Li Wei; Zhiwei Lu; Wenjun Wei; Hui Cai; Bing Wang; Wengui Shi; Nan Ding; He Li; Yanan Zhang; Jufang Wang
Journal:  Cell Cycle       Date:  2017-09-12       Impact factor: 4.534

Review 4.  Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.

Authors:  Claire Lhuillier; Claire Vanpouille-Box; Lorenzo Galluzzi; Silvia Chiara Formenti; Sandra Demaria
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

Review 5.  Autophagy-regulating microRNAs: potential targets for improving radiotherapy.

Authors:  Hongbin Li; Xiaodong Jin; Bing Chen; Ping Li; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-03       Impact factor: 4.553

6.  NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.

Authors:  Nadire Duru; Ramkishore Gernapudi; Yongshu Zhang; Yuan Yao; Pang-Kuo Lo; Benjamin Wolfson; Qun Zhou
Journal:  Cancer Lett       Date:  2015-08-20       Impact factor: 8.679

Review 7.  Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.

Authors:  Iris Eke; Adeola Y Makinde; Molykutty J Aryankalayil; Mansoor M Ahmed; C Norman Coleman
Journal:  Cancer Lett       Date:  2016-01-29       Impact factor: 8.679

Review 8.  Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review.

Authors:  Tayebeh Oghabi Bakhshaiesh; Rezvan Esmaeili
Journal:  Cell Cycle       Date:  2022-02-02       Impact factor: 5.173

Review 9.  Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

Authors:  Nina Petrović; Irina Nakashidze; Milica Nedeljković
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-21       Impact factor: 2.673

10.  Investigation of miR-93-5p and its effect on the radiosensitivity of breast cancer.

Authors:  Chi Pan; Guangzhi Sun; Min Sha; Peng Wang; Yawen Gu; Qingtao Ni
Journal:  Cell Cycle       Date:  2021-05-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.